Voce Capital Management

Will Medtronic abandon inversion in Covidien deal? | Medtech Wall Street news for the week of August 18, 2014

August 21, 2014 By MassDevice Contributors Network Leave a Comment

Will Medtronic follow Walgreen and abandon inversion in Covidien deal?

August 15, 2014 by Brad Perriello

Activist investor battles on over ConMed as shareholders vote approaches

August 14, 2014 By Brad Perriello Leave a Comment

Hedge funds battle over ConMed's board as shareholders meeting approaches

Embattled ConMed surges on reports of potential sale

April 16, 2014 By Arezu Sarvestani Leave a Comment

Surgical devices maker ConMed (NSDQ:CNMD) got a little Wall Street love after news sources reported today that the company may be up for sale.

K2M Group Holdings looks to raise $100M in IPO | Medtech Wall Street stories for the week of Mar. 17, 2014

March 19, 2014 By MassDevice staff Leave a Comment

Spinal firm K2M aims for $100M IPO

March 14, 2014 by Arezu Sarvestani

ConMed delays annual meeting amid proxy war

March 17, 2014 By Brad Perriello Leave a Comment

ConMed (NSDQ:CNMD) said last week that it’s delaying its annual shareholders meeting amid a 3-way proxy war that turned nasty last month.

Medtech personnel moves for the week of Mar. 10, 2014

March 11, 2014 By MassDevice staff Leave a Comment

ConMed proxy war gets ugly

February 28, 2014 by Brad Perriello

The proxy war over control of the board at ConMed turned ugly this week after serious allegations surfaced against 1 of the medical device company’s nominees for director.

ConMed proxy war gets ugly

February 28, 2014 By Brad Perriello Leave a Comment

UPDATED March 4, 2014, with comment from Coppersmith Capital.

The proxy war over control of the board at ConMed (NSDQ:CNMD) turned ugly this week after serious allegations surfaced against 1 of the medical device company’s nominees for director.

ConMed responds to activist investor

November 12, 2013 By Brad Perriello Leave a Comment

ConMed (NSDQ:CNMD) today responded to a long and critical letter from Voce Capital Management issued last week that demanded steps toward a strategic exit and the end "a culture of nepotism, patronage and dystopian corporate governance."

ConMed battles ‘activist investor’ amid harsh quarter, lowered forecast

November 4, 2013 By Arezu Sarvestani Leave a Comment

Corrected November 11 2013, at 2:45 p.m.

Voce Capital Management

Will Medtronic abandon inversion in Covidien deal? | Medtech Wall Street news for the week of August 18, 2014

Will Medtronic follow Walgreen and abandon inversion in Covidien deal?

August 15, 2014 by Brad Perriello

Activist investor battles on over ConMed as shareholders vote approaches

Embattled ConMed surges on reports of potential sale

K2M Group Holdings looks to raise $100M in IPO | Medtech Wall Street stories for the week of Mar. 17, 2014

Spinal firm K2M aims for $100M IPO

March 14, 2014 by Arezu Sarvestani

ConMed delays annual meeting amid proxy war

Medtech personnel moves for the week of Mar. 10, 2014

ConMed proxy war gets ugly

February 28, 2014 by Brad Perriello

ConMed proxy war gets ugly

ConMed responds to activist investor

ConMed battles ‘activist investor’ amid harsh quarter, lowered forecast

MASSDEVICE MEDICAL NETWORK

DeviceTalks Webinars, Podcasts, & Discussions

MASSDEVICE

Voce Capital Management

August 15, 2014 by Brad Perriello

March 14, 2014 by Arezu Sarvestani

February 28, 2014 by Brad Perriello

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks Webinars, Podcasts, & Discussions

MASSDEVICE